0001209191-23-004146.txt : 20230119
0001209191-23-004146.hdr.sgml : 20230119
20230119214721
ACCESSION NUMBER: 0001209191-23-004146
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230117
FILED AS OF DATE: 20230119
DATE AS OF CHANGE: 20230119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Melemed Allen S.
CENTRAL INDEX KEY: 0001815774
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35867
FILM NUMBER: 23538783
MAIL ADDRESS:
STREET 1: C/O CHIMERIX, INC.
STREET 2: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHIMERIX INC
CENTRAL INDEX KEY: 0001117480
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330903395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 919.806.1074
MAIL ADDRESS:
STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100
CITY: DURHAM
STATE: NC
ZIP: 27713
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-17
0
0001117480
CHIMERIX INC
CMRX
0001815774
Melemed Allen S.
C/O CHIMERIX, INC.
2505 MERIDIAN PARKWAY, SUITE 100
DURHAM
NC
27713
0
1
0
0
Chief Medical Officer
Common Stock
2023-01-17
4
A
0
25740
0.00
A
47887
D
Stock Option (Right to Buy)
1.97
2023-01-17
4
A
0
154260
0.00
A
2033-01-16
Common Stock
154260
154260
D
The shares being reported are being issued pursuant to restricted stock unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 6,435 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 6,435 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 6,435 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 6,435 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.
Includes 4,345 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on March 10, 2021, 6,414 shares acquired under the ESPP on September 10, 2021, 6,707 shares acquired under the ESPP on March 10, 2022 and 4,681 shares acquired under the ESPP on September 9, 2022.
1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.
/s/ Michael Alrutz, Attorney-in-Fact
2023-01-19